These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


445 related items for PubMed ID: 27662908

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
    Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators.
    Hypertension; 2008 Jul; 52(1):100-6. PubMed ID: 18504323
    [Abstract] [Full Text] [Related]

  • 24. Reliability of electrocardiographic surrogates of left ventricular mass in patients with chronic kidney disease.
    Cordeiro AC, Lindholm B, Sousa MG, Picotti JC, Nunes GJ, Santana MR, Grimaldi W, Amparo FC, Amodeo C, Carrero JJ.
    J Hypertens; 2014 Feb; 32(2):439-45. PubMed ID: 24317549
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The relationship between electrocardiographic left ventricular hypertrophy criteria and echocardiographic mass in patients undergoing transcatheter aortic valve replacement.
    Sjöberg S, Sundh F, Schlegel T, Maynard C, Rück A, Wagner G, Ugander M.
    J Electrocardiol; 2015 Feb; 48(4):630-6. PubMed ID: 25865909
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients.
    Ishikawa J, Yamanaka Y, Toba A, Watanabe S, Harada K.
    Int Heart J; 2017 Dec 12; 58(6):933-938. PubMed ID: 29162779
    [Abstract] [Full Text] [Related]

  • 35. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May 12; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 May 12; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 39. Performance of Electrocardiographic Criteria for Echocardiographically Diagnosed Left Ventricular Hypertrophy in Chinese Hypertensive Patients.
    Wang D, Xu JZ, Zhang W, Chen Y, Li J, An Y, Bian R, Wang JG.
    Am J Hypertens; 2020 Sep 10; 33(9):831-836. PubMed ID: 32484222
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 23.